Dr. Gin oversees clinical quality and safety for more than 25,000 physicians nationwide across eight Kaiser Permanente regions and 12.4 million members, resulting in some of the best performance in the country. She leads national quality strategy development, performance oversight on healthcare effectiveness data and information set measures, and alignment of care systems to enhance patient outcomes. As co-lead of the Kaiser Permanente national quality committee, she provides executive sponsorship for key clinical areas such as cancer care, mental health, women’s and children’s health, and telehealth. In her role as medical director of quality and clinical analysis for Pasadena-based Southern California Permanente Medical Group, she also oversees regional research efforts, that publish over 400 peer-reviewed articles annually. Dr. Gin has contributed nationally through the U.S. Health and Human Services Health Quality Summit and the NCQA standards committee, advocating for public service, telehealth and health equity. A dedicated educator and thought leader, she has received multiple awards for her teaching and academic contributions.
